|
Glen
A. Fine Named New Executive Vice President of NCCLS/Clinical
and Laboratory
Standards Institute
FOR
IMMEDIATE RELEASE
Contact:
Melissa J. D'Archangelo, Director of Communications,
610.688.0100
Wayne,
PA - September 27, 2004 - Dr. Thomas L. Hearn, NCCLS
President, has announced the
appointment
of Glen A. Fine, M.T.(ASCP), M.S., M.B.A, as the
organization's next
Executive Vice President, succeeding John V. Bergen, Ph.D.
Mr. Fine will
join NCCLS on 1 November.
Mr.
Fine is currently Vice President, Ethics, Regulatory
Compliance, and Privacy,
for MDS Laboratories, U.S. Inc. in Brentwood, TN. He
previously served as the Vice
President, Operations for MDS; as General Manager of MDS
Hudson Valley Laboratories; as Administrative
Director, Laboratory at Paoli Memorial
Hospital in Paoli, Pennsylvania; and as Assistant
Administrator of
the
Hospital of the University of Pennsylvania. Mr. Fine’s
educational background
includes a Master of Business Administration degree in
Health Care Administration from St.
Joseph’s University and a Master of Science in Clinical
Laboratory Sciences from Temple University, Philadelphia,
PA.
As
Executive Vice President and chief staff officer, Mr. Fine
will have overall
responsibility for the strategic, programmatic,
administrative, marketing, and
financial management operations of the organization; for
communicating the
organization’s vision and objectives to its internal and
external
constituencies; and for providing leadership to the Board of
Directors and staff in formulating policy,
developing strategy, and implementing
programs.
Mr.
Fine takes on this NCCLS leadership role at an exciting time
in its history.
On 1 January 2005, NCCLS will officially change its name,
becoming the Clinical and Laboratory
Standards Institute (CLSI). The new name best reflects
the organization’s mission to the healthcare community,
depth and breadth
of standards-development activities, and global membership
base.
Commenting
on his new role, Mr. Fine said "I am very excited to
join NCCLS, an
organization which enjoys an outstanding reputation for
quality in all of its products and
services. With the upcoming name change to CLSI, to
reflect an ambitious growth agenda beyond its
traditional boundaries, I am delighted
to be part of the organization at such an exciting time in
its
history."
Selection
of Mr. Fine, from among many highly qualified candidates,
successfully completes a year-long search.
The Search Committee was chaired by
Dr. Hearn. The committee’s members included Dr. Donna M.
Meyer (Immediate Past President),
Wayne Brinster (NCCLS Secretary), Dr. Mary Lou Gantzer
and James A. Thomas (both members of the Board of
Directors), and
Jeffrey
Koeppel.
According
to Dr. Hearn, "Mr. Fine and NCCLS is a very good match!
Mr. Fine's
experience in management, marketing, and finance, and his
results-oriented approach and style bode well
for NCCLS. I am confident that
with his leadership NCCLS will become even more prominent as
the
world's
finest clinical and laboratory standards-development
organization. NCCLS
has had tremendous growth, masterfully guided by Dr. John V.
Bergen, NCCLS's outgoing Executive
Vice President. I know Mr. Fine welcomes the challenges
in moving NCCLS to even higher levels."
Dr.
Bergen, who has served as Executive Director and, more
recently, Executive
Vice President, will retire on 31 December, after 23 years
of outstanding
service.
For
additional information on NCCLS or for further information
regarding this
release, visit our Website at http://www.nccls.org
or call+610.688.0100.
NCCLS
is a global, non-profit, membership-based organization
dedicated to developing standards and guidelines for the
healthcare and medical testing community. NCCLS's unique
consensus process facilitates the creation of standards and
guidelines that are reliable, practical, and achievable for
an effective quality system.
|